These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 10500831)
1. Defining the optimal dosage of methotrexate for childhood acute lymphoblastic leukemia. New insights from the lab and clinic. Evans WE; Pui CH; Relling MV Adv Exp Med Biol; 1999; 457():537-41. PubMed ID: 10500831 [No Abstract] [Full Text] [Related]
2. Does pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of children with acute lymphoblastic leukemia: what can we learn from small studies? Evans WE; Relling MV; Boyett JM; Pui CH Leuk Res; 1997 May; 21(5):435-7. PubMed ID: 9225072 [No Abstract] [Full Text] [Related]
3. Treatment of Czech children with acute lymphoblastic leukemia: a report of the Czech Working Group for Pediatric Hematology. Starý J; Gajdos P; Hrstková H; Blazek B; Slavík Z; Mihál V; Zahálka F; Jabali Y; Vávra V; Kopecná L; Mydlil J; Trka J Med Pediatr Oncol; 2002 Aug; 39(2):125-7. PubMed ID: 12116061 [No Abstract] [Full Text] [Related]
5. [Assessment of elimination and tolerance of high dose of methotrexate (3 g/m2) in children with standard-risk acute lymphoblastic leukemia]. Cwliklińska M; Balwierz W; Nowak J; Stanuch H Przegl Lek; 2006; 63(1):15-20. PubMed ID: 16892893 [TBL] [Abstract][Full Text] [Related]
6. Population PK/PD model of homocysteine concentrations after high-dose methotrexate treatment in patients with acute lymphoblastic leukemia. Rühs H; Becker A; Drescher A; Panetta JC; Pui CH; Relling MV; Jaehde U PLoS One; 2012; 7(9):e46015. PubMed ID: 23049924 [TBL] [Abstract][Full Text] [Related]
7. The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX). Giverhaug T; Loennechen T; Aarbakke J Gen Pharmacol; 1999 Oct; 33(4):341-6. PubMed ID: 10523073 [TBL] [Abstract][Full Text] [Related]
8. [Investigation on individualized adjustment of target range of high-dose methotrexate]. Hua Y; Zhao WH; Lu XT; Yang LH; Lu W Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):203-8. PubMed ID: 19099710 [TBL] [Abstract][Full Text] [Related]
9. Delayed Methotrexate Elimination after Administration of a Medium Dose of Methotrexate in a Patient with Genetic Variants Associated with Methotrexate Clearance. Tatebe Y; Kanamitsu K; Kanzaki H; Ishida H; Fujiwara K; Washio K; Kitamura Y; Sendo T; Shimada A; Tsukahara H Acta Med Okayama; 2020 Dec; 74(6):545-550. PubMed ID: 33361876 [TBL] [Abstract][Full Text] [Related]
10. Repeated Episodes of Leukoencephalopathy after High-dose Methotrexate in a Child with Acute Lymphoblastic Leukemia. Tsao TF; Chao YH Indian Pediatr; 2017 Feb; 54(2):159. PubMed ID: 28285295 [No Abstract] [Full Text] [Related]
12. Delayed elimination of methotrexate in a patient receiving ciprofloxacin. Aouinti I; Gaïes E; Trabelsi S; Salouage I; Jebabli N; Charfi R; Lakhal M; Klouz A Therapie; 2013; 68(3):175-7. PubMed ID: 23886465 [No Abstract] [Full Text] [Related]
13. Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Whitehead VM; Shuster JJ; Vuchich MJ; Mahoney DH; Lauer SJ; Payment C; Koch PA; Cooley LD; Look AT; Pullen DJ; Camitta B Leukemia; 2005 Apr; 19(4):533-6. PubMed ID: 15716987 [TBL] [Abstract][Full Text] [Related]
14. Optimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia. Estlin EJ; Lowis SP; Hall AG Br J Haematol; 2000 Jul; 110(1):29-40. PubMed ID: 10930977 [No Abstract] [Full Text] [Related]
15. High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations. Rau T; Erney B; Göres R; Eschenhagen T; Beck J; Langer T Clin Pharmacol Ther; 2006 Nov; 80(5):468-76. PubMed ID: 17112803 [TBL] [Abstract][Full Text] [Related]
16. Reversal of neurologic disturbances related to high-dose methotrexate by aminophylline. Peyriere H; Poiree M; Cociglio M; Margueritte G; Hansel S; Hillaire-Buys D Med Pediatr Oncol; 2001 Jun; 36(6):662-4. PubMed ID: 11344503 [No Abstract] [Full Text] [Related]
17. High-dose methotrexate is lethal to rats. Why give it to children? Cole PD; Kamen BA Pediatr Hematol Oncol; 2000 Dec; 17(8):609-13. PubMed ID: 11127392 [No Abstract] [Full Text] [Related]
18. [Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia]. Xu WQ; Tang YM; Fang CQ; Song H; Shi SW; Yang SL; Ren DT; Shen HQ; Qian BQ Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):15-8. PubMed ID: 15946502 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid concentrations of nitrate plus nitrite during the treatment of acute lymphoblastic leukaemia in childhood. Surtees R; Clelland J; Heales S Leuk Res; 1998 Aug; 22(8):751-4. PubMed ID: 9680103 [TBL] [Abstract][Full Text] [Related]
20. In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile. Sorich MJ; Pottier N; Pei D; Yang W; Kager L; Stocco G; Cheng C; Panetta JC; Pui CH; Relling MV; Cheok MH; Evans WE PLoS Med; 2008 Apr; 5(4):e83. PubMed ID: 18416598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]